Your browser doesn't support javascript.
loading
Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
Gao, Chao; Liu, Shu-Guang; Lu, Wen-Ting; Yue, Zhi-Xia; Zhao, Xiao-Xi; Xing, Tian-Yu; Chen, Zhen-Ping; Zheng, Hu-Yong; Li, Zhi-Gang.
Afiliación
  • Gao C; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Liu SG; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Lu WT; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Yue ZX; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Zhao XX; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Xing TY; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Chen ZP; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Zheng HY; Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing 100045, P.R. China.
  • Li ZG; Hematology and Oncology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, P.R. China.
Mol Med Rep ; 22(4): 2905-2915, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32945392
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daunorrubicina / Regulación hacia Abajo / Resistencia a Antineoplásicos / Proliferación Celular / Proteína de Unión a CREB / Leucemia-Linfoma Linfoblástico de Células Precursoras / Puntos de Control del Ciclo Celular / Antibióticos Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Med Rep Año: 2020 Tipo del documento: Article Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daunorrubicina / Regulación hacia Abajo / Resistencia a Antineoplásicos / Proliferación Celular / Proteína de Unión a CREB / Leucemia-Linfoma Linfoblástico de Células Precursoras / Puntos de Control del Ciclo Celular / Antibióticos Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Med Rep Año: 2020 Tipo del documento: Article Pais de publicación: Grecia